Biocon | Page 2 | Business Upturn

Latest Articles

Biocon subsidiary and Yoshindo expand access to Ustekinumab Biosimilar in Japan

Corporates · May 21, 2025

blank

Biocon share price jumps 4% after its subsidiary receives multiple market access agreements for Yesintek

Stock Market · May 5, 2025

blank

Biocon Biologics secures multiple US market access for Yesintek

Corporates · May 5, 2025

blank

Biocon shares jump 3% as its subsidiary secures US market entry for Yesafili

Stock Market · Apr 15, 2025

blank

Biocon Biologics receives U.S. FDA approval for bevacizumab biosimilar JOBEVNE

Corporates · Apr 10, 2025

blank

Biocon Pharma secures US FDA approvals for Lenalidomide, Dasatinib, and Rivaroxaban tablets

Corporates · Mar 4, 2025

By Aditya Bhagchandani

blank

Biocon launches Liraglutide for diabetes and obesity in the UK

Corporates · Feb 28, 2025

blank

Biocon shares surge 2.2% after its subsidiary launches YESINTEK™ in the US

Stock Market · Feb 25, 2025

blank

Biocon Biologics launches YESINTEK™ in the United States

Corporates · Feb 24, 2025

blank

Biocon shares up nearly 3% as Q3 results highlight EBITDA growth of 16% and revenue rise of 7%

Stock Market · Jan 31, 2025

By Aditya Bhagchandani

blank

Top Q3 FY25 Results Today on January 30, 2025: Adani Enterprises, Adani Ports, Bajaj Finserv, BEL, Biocon, Dabur, Prestige Estates

Corporates · Jan 30, 2025

By Aditya Bhagchandani

blank

Biocon shares surge nearly 4% as HSBC upgrades to ‘Buy’

Stock Market · Jan 14, 2025

By Aditya Bhagchandani

blank

Biocon shares surge 4% today; Motilal Oswal upgrades stock to Buy

Stock Market · Jan 13, 2025

By Aditya Bhagchandani

blank

Biocon shares jump 3% as U.S. FDA classifies Johor Bahru facility as VAI

Stock Market · Jan 13, 2025

blank

Top stocks to watch in trade today: DMart, PCBL, Biocon, Just Dial, Waaree Energies and more

Stock Market · Jan 13, 2025

Showing 30 of 599,459 articles